WaferGen to Present at the Sanders Morris Harris Third Annual Investor Growth Conference
Posted on: Tuesday, 30 October 2007, 09:01 CDT
FREMONT, Calif., Oct. 30 /PRNewswire-FirstCall/ -- WaferGen Biosystems, Inc. (BULLETIN BOARD: WGBS) , a leading developer of state-of-the-art gene expression, genotyping, cell biology and stem cell research systems, today announced that Mr. Alnoor Shivji, President and Chief Executive Officer, will deliver a corporate presentation at the Sanders Morris Harris Third Annual Investor Growth Conference. The conference will be held November 8-9, 2007, at the New York Palace Hotel in New York City.
Mr. Shivji's presentation will take place at 11:30 a.m. EST on Thursday, November 8th. The presentation will include an overview of the company's SmartChip(TM) product which is currently being developed for the gene expression and genotyping markets, and the SmartSlide(TM) product that WaferGen is actively marketing. A live webcast and 30-day archive of the presentation can be accessed at http://www.wafergen.com/.
About WaferGen
WaferGen Biosystems, Inc. is a leader in the development, manufacture and sale of state-of-the-art systems for gene expression, genotyping, cell biology and stem cell research for the life science and pharmaceutical industries. The company is actively developing its SmartChip(TM) product for the gene expression and genotyping markets. SmartChip(TM) is being developed as the first whole genome, high throughput gene expression Real-Time Polymerase Chain Reaction (Real-Time PCR) platform and promises to deliver significant speed and cost advantages to researchers in the gene expression and genotyping markets. WaferGen currently markets its SmartSlide(TM) family of products to companies and organizations involved in stem cell and cell biology research. SmartSlide(TM), which was launched in 2006, represents the first fluidics integrated micro-incubators enabling cell biology and stem cell research. Representative SmartSlide(TM) customers include Harvard University, Mayo Clinic, Memorial Sloan-Kettering Cancer Center, Abbott Labs, and the National Institutes of Health (NIH).
To learn more about WaferGen, please visit the company's web site at http://www.wafergen.com/.
Contact: Vida Communication (On behalf of WaferGen) Stephanie Diaz (investors) Tim Brons (media) 415-675-7400 415-675-7402 sdiaz@vidacommunication.com tbrons@vidacommunication.com
WaferGen Biosystems, Inc.
CONTACT: investors, Stephanie Diaz, +1-415-675-7400,sdiaz@vidacommunication.com, or media, Tim Brons, +1-415-675-7402,tbrons@vidacommunication.com, both of of Vida Communication for WaferGenBiosystems, Inc.
Web site: http://www.wafergen.com/
Source: PRNewswire-FirstCall
Related Articles
- Smart Rat Produced By Over-Expressing Gene That Helps Brain Cells Communicate
- Data on WaferGen's SmartChip Real-Time PCR System(TM) to be Presented at 16th International Molecular Medicine Tri-Conference
- WaferGen Launches SmartSlide 200 Micro-Incubation System for Stem Cell Research and Cell Biology Applications
- Introgen's ADVEXIN Clinical Biomarker Data Presented at Conference on Licensure of Cell and Gene Therapy Products
- MaxCyte is Featured Speaker at the Phacilitate Cell and Gene Therapy Forum 2007
- Adult cells in mice shown to mimic embryonic stem cells
- The Recessive Epigenetic Swellmap Mutation Affects the Expression of Two Step II Splicing Factors Required for the Transcription of the Cell Proliferation Gene STRUWWELPETER and for the Timing of Cell Cycle Arrest in the Arabidopsis Leaf
- Vectors; Enzyme protects cells during gene therapy
- University of Florida; Enzyme protects cells during gene therapy
- Stem Cell 'Master Gene' Found
 |
 |
User Comments (0)
RSS Feeds